Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current Assets
Cash	$ 235,452	$ 232,984
Trade accounts receivable, net	451,074	154,436
Inventory, net	179,255	61,051
Total Current Assets	865,781	448,471
Current Liabilities
Accounts payable and accrued expenses	421,640	167,481
Notes payable	100,000	100,000
Total Current Liabilities	521,640	267,481
Immudyne, Inc. Stockholders' equity
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,310,375 and 32,010,375 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively	343,103	320,103
Additional paid-in capital	8,783,487	8,366,313
Accumulated (deficit)	(8,848,363)	(8,586,338)
Total Immudyne, Inc. Stockholders' Equity	278,227	100,078
Non-controlling interest	65,914	80,912
Total Stockholders' Equity	344,141	180,990
Total Liabilities and Stockholders' Equity	$ 865,781	$ 448,471

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.